Guaifenesin And Pseudoephedrine Hcl 58602-0834
Product NDC
58602-0834- Manufacturer
- Aurohealth Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 25, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213203
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 1200 mg/1 |
| Pseudoephedrine Hydrochloride | 120 mg/1 |
Drug Class
Expectorant [EPC]Adrenergic alpha-Agonists [MoA]Decreased Respiratory Secretion Viscosity [PE]
Packaging Options(2)
1 BLISTER PACK in 1 CARTON (58602-834-77) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
2 BLISTER PACK in 1 CARTON (58602-834-78) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK